GPAT- 2024
|
Processes |
Timelines |
|
आवेदन ऑनलाइन जमा करना Online Submission of Applications |
19 अप्रैल 2024 (दोपहर 3 बजे के बाद) से 8 मई 2024 (11:55 रात तक) 19th April 2024 (3 PM Onwards) to 8th May 2024 (Till 11:55PM) |
|
सभी सफल भुगतान आवेदन के Aलए स ादन QवRडो Edit Window for All Payment Success Applications (Any information/documents can be edited except Name, Nationality, Email, Mobile number and Test City) |
11 मई 2024 से 14 मई 2024 तक 11th May 2024 to 14th May 2024 |
|
दोषपूण/गलत छवय को सुधारने के Aलए अंQतम एवं चयना क संपादन QवRडो: Final and Selective Edit Window to rectify Deficient/Incorrect Images (No further opportunity shall be given) 1. फ़ोटोग्राफ़/Photograph 2. हस्ताक्षर/Signatures 3. अंगूठे का िनशान/Thumb Impression |
ी-फ़ाइनल संपादन QवRडो: 21 मई से 23 मई 2024 अंQतम संपादन QवRडो: 28 मई से 30 मई 2024 Pre-Final Edit Window: 21st May to 23rd May 2024 Final Edit Window: 28th May to 30th May 2024 |
|
वेश प जारी करना Issue of Admit Card |
3 जून 2024 3rd June 2024 |
|
परी ा क] Qत^थ Examination Date |
8 जून 2024 8th June 2024 |
|
प`रणाम क] घोषणा Declaration of Result |
8 जुलाई 2024 तक By 8th July 2024 |
Eligibility Criteria
The candidate must meet/fulfil the following criteria:
- He / She is a citizen of India.
- The candidate must hold a Bachelor’s degree in Pharmacy (4 years after 10+2, including lateral entry students) or equivalent from a recognized university.
- Candidates appearing for the final year (4th Year) examination of Bachelor of Pharmacy (B. Pharm) whose result will be declared before commencement of admission to M. Pharm course for the academic year 2024-25 are eligible to appear in GPAT 2024. Candidates appearing for the Prefinal year (3rd Year) examination of Bachelor of Pharmacy (B. Pharm) whose results for Final Year (4th Year) will be declared before commencement of admission to M. Pharm course for the academic year 2025-26 are also eligible to appear in GPAT 2024.
- B.E./ B.Tech. (Pharmaceutical and Fine Chemical Technology)/ equivalent candidates are not eligible to appear in GPAT 2024.
- Candidates found to be ineligible at any stage of GPAT 2024 will not be permitted to appear in the examination and/or counseling. In an unlikely event of any ineligible candidate appearing and/or being successful in the GPAT 2024, the results/ candidature of such candidate shall be cancelled and/or are deemed to be cancelled.
- Eligibility of candidates issued admit card for the examination shall be purely provisional. Appearance in GPAT 2024 does not confer any automatic rights upon the candidate for admission to M. Pharm courses and/or award of scholarship.
- Candidates are advised not to canvass with NBEMS for eligibility in GPAT or issuance of admit card. Queries, if any, can be submitted through Communication Web Portal only. Canvassing in any form shall invite rejection of the application.
Scheme of GPAT 2024
- GPAT 2024 shall be conducted in a single day & single session as a computer based examination on 8th June 2024.
- Syllabus: The syllabus for the GPAT shall comprise of subject/knowledge areas as per “The Bachelor of Pharmacy (B. Pharm.) Course Regulations, 2024”.
- The examination shall be a multiple choice questions test delivered using computers network (CBT) as per scheme prescribed. An indicative Blueprint of the examination is as under:
|
Type of Questions |
No. of Questions |
Maximum Marks |
|
Pharmaceutical Chemistry & Allied Subjects |
38 |
152 |
|
Pharmaceutics & Allied Subjects |
38 |
152 |
|
Pharmacognosy & Allied Subjects |
10 |
40 |
|
Pharmacology & Allied Subjects |
28 |
112 |
|
Other Subjects of B. Pharm course |
11 |
44 |
|
Total |
125 |
500 |
- The exam comprises of 125 Multiple
- Choice Questions with each question having 4 response options/ distractors in English language only. Candidates are required to select the correct/best/most appropriate response/answer out of the 4 response options provided in each question. Time allotted is 3 hrs (180 minutes).
- Marking Scheme: Allocation of marks for each MCQ shall be as follows:
|
S.NO. |
RESPONSE |
MARKS |
|
1 |
Correct Response |
4 Marks |
|
2 |
Incorrect Response |
1 Mark shall be deducted |
|
3 |
Unattempted Question |
Zero |
- There shall be 25% negative marking for incorrect answers. No marks will be deducted for unattempted questions.
- The question paper for GAPT will be divided into multiple time bound sections. For example, if there are 5-time bound sections* (Section A, B, C, D & E) in the question paper, each Section will have 25 questions and 36 minutes of time allotted for the section. Candidates would be restricted to proceed to the next section only after completion of the allotted time of the previous section and candidates would not be allowed to review the questions/modify the responses of a section after the completion of the allotted time of that section. Questions of the next section will start automatically after the completion of the allotted time of the previous section.
- The actual number of such time-restricted sections may vary based on the total number of questions in the question paper and operational feasibility in making such sections.
- Candidates are given an option to mark any question, whether attempted or not, for review which means that candidate has been given an option to go through these questions in a section again before the allotted time to a section ends. Candidates may note that such questions which are marked for review shall be evaluated as per the marking scheme mentioned above.
Summary of Steps in Online Application Form Submission
The following sequence shall be observed while filing the online application form:
• Fill the user registration form to generate User ID/Application ID and Password.
• User ID and Password will be sent through SMS and Email.
• Complete the application form and upload your Photograph, Scanned signature,
Thumb impression & Prescribed documents.
• Choose your Test City and pay Examination Fee
• Agree to the declaration and Submit Application
Examination Fee
|
Category of Candidate |
Examination Fee |
|
General, OBC and EWS |
Rs. 3500/- |
|
SC, ST, PWD |
Rs. 2500/- |
0 Comments